Topic: Health and Human Services Sector
OSI board rejects Astellas' $3.5 billion offer
AP News
OSI Pharmaceuticals' board of directors rejects Astellas Pharma's $3.5 billion takeover bidOSI Pharmaceuticals rejected a $3.5-billion takeover bid from Astellas Pharma Inc., telling shareholders Monday the offer was too low. Astellas has attempted to acquire OSI for more than a year and, after repeated rejections, the Japanese ...
New CEO, chairman appointed at Bausch & Lomb
AP Features
Two former Schering-Plough executives are taking charge at Bausch & Lomb, whose chairman and CEO is retiring after guiding the company through the aftermath of a devastating contact lens recall. The Rochester, N.Y.-based eye care products maker says that Brent Saunders has been appointed chief executive and Fred ...
Amylin shares up on FDA response for diabetes drug
AP News
Amylin Pharmaceuticals shares rise on FDA response for once-weekly diabetes drugShares of Amylin Pharmaceuticals jumped 13 percent Monday as the Food and Drug Administration asked for more information on its potential diabetes treatment. Amylin, along with partners Eli Lilly & Co. and Alkermes Inc., were not asked to conduct additional ...
Merck blood thinner appears safe, effective
Reuters US Online Report Health News
ATLANTA (Reuters) - An experimental blood thinner being developed by Merck & Co from a new class of drugs appeared to be safe and effective in a mid-stage study that compared three doses against widely used warfarin in patients with atrial fibrillation. Betrixaban, which Merck is developing through a licensing deal ...
Related Videos by 5min
on OneRiot
Related Photos by Flickr
